DR. TED GUTOWSKI, M.D.

FREEHOLD, NJ

Research Active
Internal Medicine - Cardiovascular Disease NPI registered 21+ years 13 publications 1985 – 2025 NPI: 1669476073
AlgorithmsDatabases, FactualMachine LearningQuality of LifeSmartphoneNeural Networks, ComputerPrecision MedicineParkinson DiseaseBenchmarkingCoronary DiseaseWearable Electronic DevicesAngioplasty, Balloon, CoronaryDrug LiberationPowdersTremor

Practice Location

901 W MAIN ST
FREEHOLD, NJ 07728-2537

Phone: (732) 866-0800

What does TED GUTOWSKI research?

Dr. Gutowski studies various health conditions, largely centering on the effects of chemotherapy in children and the management of Parkinson's disease. His research involves developing 3D-printed medications that are easier for children to take, as well as using machine learning technology to better track Parkinson's symptoms. Additionally, he explores new techniques to tailor medication schedules for Parkinson's patients, improving their quality of life. Through his work, he aims to make treatments more effective and patient-friendly, ensuring that individuals receive the most appropriate care for their specific needs.

Key findings

  • Developed 3D-printed chewable dexamethasone tablets for children undergoing chemotherapy, showing effective taste masking and a drug release time within 2 hours.
  • Achieved over 96% accuracy in creating personalized medication schedules for Parkinson's disease patients, significantly reducing errors and enhancing care.
  • Analyzed 1,406 CT scans to classify knee deformities for total knee replacements, finding that 36.9% of cases had varus deformity and 34.3% had valgus deformity.
  • Created a new data architecture for assessing motor symptoms in Parkinson's disease, resulting in improved organization and accuracy in symptom measurement.
  • Developed mucoadhesive buccal films that improved drug delivery in the mouth, lasting longer than traditional films.

Frequently asked questions

Does Dr. Gutowski study treatments for chemotherapy-induced nausea and vomiting?
Yes, he has developed 3D-printed dexamethasone tablets designed to help children avoid nausea and vomiting during chemotherapy.
What technologies does Dr. Gutowski use in his research on Parkinson's disease?
He uses machine learning and wearable devices to better assess and manage symptoms of Parkinson's disease.
Is Dr. Gutowski's work relevant to patients with knee deformities?
Absolutely, his research includes a classification system for knee deformities that enhances planning for total knee replacement surgeries.
What innovations has Dr. Gutowski introduced for medication delivery?
He has created new drug delivery methods such as 3D-printed tablets and mucoadhesive films that stick to the mouth, providing easier medication administration.
How does Dr. Gutowski's research help improve patient care?
His studies target the development of more effective treatments and better management strategies, improving the overall care and quality of life for patients with various conditions.

Publications in plain English

Machine Learning-Based Assessment of Parkinson's Disease Symptoms Using Wearable and Smartphone Sensors.

2025

Sensors (Basel, Switzerland)

Gutowski T, Stodulska O, Ćwiklińska A, Gutowska K, Kopeć K +4 more

Plain English
This study looked at how machine learning can help assess Parkinson's disease symptoms using data from wearable devices and smartphones. The researchers found that combining data from a special armband and smartphones produced the best predictions, with tremors being the easiest symptom to forecast. This is important because it shows that using both technology and patient input can improve monitoring of symptoms, though more data is needed to get better results for all types of symptoms. Who this helps: This helps both patients and doctors by providing better ways to track and understand Parkinson's symptoms.

PubMed

Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children.

2025

International journal of pharmaceutics: X

Dadkhah A, Gutowski T, Wansing EM, von Hugo A, Woessmann W +4 more

Plain English
Researchers created 3D-printed chewable tablets of dexamethasone (Dexa) to help children undergoing chemotherapy avoid nausea and vomiting. The new tablets were made to be more palatable, maintaining a consistent dose with minimal bitterness, showing effective results in taste masking. They performed well in tests, with drug release completed within 2 hours and good stability for at least 5 weeks, making them a promising option for children’s treatment. Who this helps: This benefits children undergoing chemotherapy and their doctors.

PubMed

Three-dimensional-based native alignment phenotype classification system: Description for use in planning for deformities during total knee arthroplasty.

2024

Journal of orthopaedics

Marchand R, Shul C, Hameed D, Dubin J, Roche M +4 more

Plain English
This study focused on improving the planning for total knee replacement surgery by using advanced 3D CT scans instead of traditional 2D X-rays. Researchers analyzed 1,406 CT scans and developed a system called the Native Alignment Phenotype that categorizes different types of knee deformities. They discovered that the most common knee misalignments included a slight outward bend (varus deformity) in 36.9% of cases and a slight inward bend (valgus deformity) in 34.3%, which can help doctors tailor surgeries more precisely for individual patients. Who this helps: Patients with knee deformities needing surgery.

PubMed

Development of an immediate release excipient composition for 3D printing via direct powder extrusion in a hospital.

2023

International journal of pharmaceutics

Rosch M, Gutowski T, Baehr M, Eggert J, Gottfried K +4 more

Plain English
This study focused on creating a new way to make 3D-printed tablets in hospitals, specifically aiming for tablets that dissolve quickly. Researchers successfully created tablets containing Levodopa that released the drug effectively, with a high accuracy in dosing, while also being strong and stable. However, the process didn't work well for another drug, Carbidopa. This innovation is important because it can improve how medications are made and managed in hospitals, enhancing patient safety. Who this helps: This helps patients who need personalized medication in a hospital setting.

PubMed

A Unified Data Architecture for Assessing Motor Symptoms in Parkinson's Disease.

2023

Studies in health technology and informatics

Gundler C, Zhu QR, Trübe L, Dadkhah A, Gutowski T +5 more

Plain English
This research focused on improving how motor symptoms in Parkinson's disease are measured and analyzed. The authors created a new system that organizes and processes data collected from wearables and other devices, making it easier for researchers to compare results from different studies. They found that their system works well in both tests and clinical settings, but improvements are still needed to handle precise data efficiently. Who this helps: This benefits researchers studying Parkinson's disease and healthcare providers treating patients.

PubMed

Machine learning with optimization to create medicine intake schedules for Parkinson's disease patients.

2023

PloS one

Gutowski T, Antkiewicz R, Szlufik S

Plain English
This study developed a way to create personalized medication schedules for people with Parkinson's disease, using advanced technology called machine learning. The researchers found that their method reduced errors in medication schedules by creating tailored plans that improved patient care, achieving a very high prediction accuracy (over 96%). This is important because better schedules can enhance the quality of life for patients by minimizing discomfort and optimizing treatment. Who this helps: Patients with Parkinson's disease.

PubMed

Mucoadhesive buccal films based on a graft co-polymer - A mucin-retentive hydrogel scaffold.

2020

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Alopaeus JF, Hellfritzsch M, Gutowski T, Scherließ R, Almeida A +3 more

Plain English
This study focused on creating a new type of thin film that can hold and deliver medication in the mouth without the need for swallowing. Researchers combined a special polymer with other ingredients to make a film that sticks better to the inside of the mouth and lasts longer. They found that this new film made with the combined materials stayed on the mucosal surface longer than traditional single-polymer films, allowing for more effective drug delivery. Who this helps: This benefits patients who require oral medications, especially those who have difficulty swallowing.

PubMed

Why we use more materials.

2017

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences

Gutowski T, Cooper D, Sahni S

Plain English
This paper looks at why society uses so many materials and how this has changed over time. It found that increased material use is closely linked to economic growth and human well-being, with strong historical evidence showing that industrialization has driven higher consumption rates. It raises important questions about whether we can continue to improve our quality of life without relying so heavily on materials moving forward. Who this helps: This helps policymakers and environmentalists aiming to promote sustainable practices and reduce resource consumption.

PubMed

Vasospasm in a coronary artery aneurysm.

1991

Catheterization and cardiovascular diagnosis

Gutowski T, Tannenbaum AK, Moreyra AE

Plain English
This study looked at a specific case of a patient with a bulging blood vessel (aneurysm) in the right coronary artery, which is a key part of the heart's blood supply system. During a medical procedure to open this artery, the researchers found that the bulging area also experienced sudden tightening (vasospasm), which is unusual because these areas are not thought to have enough muscle to tighten significantly. This finding is important because it could change how doctors approach treatment for patients with coronary artery aneurysms, potentially improving outcomes. Who this helps: This benefits heart patients with coronary artery aneurysms.

PubMed

Over-the-wire coronary angioplasty through a diagnostic catheter.

1991

The Journal of invasive cardiology

Gutowski T, Moreyra AE

PubMed

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

1991

Circulation

Cohen MV, Byrne MJ, Levine B, Gutowski T, Adelson R

Plain English
This study looked at how cardiologists treat high cholesterol in patients with coronary artery disease at a hospital. Among 95 patients evaluated, only 17% were receiving treatment for high cholesterol shortly after their diagnosis, and by 1-2 years later, that number only improved to 35%. This is important because effective cholesterol treatment can significantly reduce the risk of heart problems, but many patients were not getting the help they needed. Who this helps: Patients with high cholesterol and coronary artery disease.

PubMed

Abrupt vessel closure following platelet transfusion post-PTCA.

1991

Catheterization and cardiovascular diagnosis

Gutowski T, Kauffman G, Lacy C

Plain English
This study looked at the effects of giving platelet transfusions after a procedure called PTCA, which is used to open blocked arteries. Researchers found that giving platelet transfusions can lead to sudden closure of the blood vessel in some cases. This is important because it suggests that doctors should avoid using platelet transfusions right after PTCA to prevent complications. Who this helps: This helps doctors in making safer treatment decisions for patients.

PubMed

Group C streptococcal arthritis and osteomyelitis in an adolescent with a hereditary sensory neuropathy.

1985

Pediatric infectious disease

Ascuitto R, Drennan J, Fitzgerald V, Gutowski T

PubMed

Frequent Co-Authors

Adrin Dadkhah Michael Baehr Claudia Langebrake Ryszard Antkiewicz Stanisław Szlufik Christopher Gundler Moritz Rosch Sylvia Nürnberg A E Moreyra Eva-Maria Wansing

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.